title: [Is pathogenetically-founded therapy of chronic inflammatory bowel disease in sight?].
authors.affiliation: Medizinische Klinik III, St.-Johannes-Hospital Duisburg-Hamborn.
authors.forename: B
authors.initials: B
authors.lastname: Miller
mesh_terms: D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000503:physiopathology; D003424:Crohn Disease / Q000188:drug therapy* / Q000503:physiopathology; D005544:Forecasting; D006801:Humans; D007375:Interleukin-1 / Q000037:antagonists & inhibitors / Q000502:physiology; D007975:Leukotriene B4 / Q000037:antagonists & inhibitors / Q000502:physiology; D008084:Lipoxygenase / Q000502:physiology; D016859:Lipoxygenase Inhibitors / Q000627:therapeutic use; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors / Q000502:physiology
chemical_list: D007375:Interleukin-1; D016859:Lipoxygenase Inhibitors; D017472:Receptors, Interleukin-1; D007975:Leukotriene B4; D008084:Lipoxygenase
vernacular_title: 1st eine pathogenetisch begründete Therapie der chronisch-entzündlichen Darmerkrankungen in Sicht?